Najat Khan insider trades
Open-market stock purchases and sales by Najat Khan, CEO and President at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 1, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 8, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold | $78.8K |
| Aug 17, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $254K |
| Jun 5, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold | $84.5K |
| May 15, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $191K |
| Mar 9, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold | $94.7K |
| Feb 17, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $49.8K |
| Feb 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $41.2K |
| Dec 22, 2025 | RXRX Recursion Pharmaceuticals, Inc | Sold | $549K |
| Nov 17, 2025 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $72.8K |
| Nov 5, 2025 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 5, 2025 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- RXRX Recursion Pharmaceuticals, Inc: 5 sales, last Sep 8, 2026